---
figid: PMC5377799__zbc0151763870008
figlink: /pmc/articles/PMC5377799/figure/F8/
number: FIGURE 8
caption: Conceptual framework of CDKN2A expression during persistent LPS senescence
  induction. Persistent cholangiocyte stress results in the activation of NRAS and
  subsequently the MAPK/ERK signaling pathway. ETS1 is up-regulated, is phosphorylated,
  and translocates to the nucleus. In the nucleus, epigenetic histone modification
  (e.g. H3K4me3) allows p-ETS1 to bind to the CDKN2A promoter, resulting in CDKN2A
  transcription and, ultimately, cellular senescence. Pharmacologic inhibition of
  RAS/MEK/ERK (manumycin A, PD98059, or UO126) and suppression of ETS1 (ETS1-shRNA
  and genome editing) prevents CDKN2A transcription and senescence.
pmcid: PMC5377799
papertitle: ETS Proto-oncogene 1 Transcriptionally Up-regulates the Cholangiocyte
  Senescence-associated Protein Cyclin-dependent Kinase Inhibitor 2A.
reftext: Steven P. O'Hara, et al. J Biol Chem. 2017 Mar 24;292(12):4833-4846.
pmc_ranked_result_index: '92530'
pathway_score: 0.7332462
filename: zbc0151763870008.jpg
figtitle: Conceptual framework of CDKN2A expression during persistent LPS senescence
  induction
year: '2017'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5377799__zbc0151763870008.html
  '@type': Dataset
  description: Conceptual framework of CDKN2A expression during persistent LPS senescence
    induction. Persistent cholangiocyte stress results in the activation of NRAS and
    subsequently the MAPK/ERK signaling pathway. ETS1 is up-regulated, is phosphorylated,
    and translocates to the nucleus. In the nucleus, epigenetic histone modification
    (e.g. H3K4me3) allows p-ETS1 to bind to the CDKN2A promoter, resulting in CDKN2A
    transcription and, ultimately, cellular senescence. Pharmacologic inhibition of
    RAS/MEK/ERK (manumycin A, PD98059, or UO126) and suppression of ETS1 (ETS1-shRNA
    and genome editing) prevents CDKN2A transcription and senescence.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK9
  - ETS1
  - IRF6
  - CDKN2A
  - MAPK8
  - MAPK10
  - MAPK11
  - MAPK1
  - MAPK3
  - MAPK12
  - NRAS
  - MAPK13
  - MAPK14
  - Manumycin H
  - UO126
genes:
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: Ets1
  symbol: ETS1
  source: hgnc_symbol
  hgnc_symbol: ETS1
  entrez: '2113'
- word: LPS)
  symbol: LPS
  source: hgnc_prev_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: P16INK4A
  symbol: p16INK4a
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: p16
  symbol: p16
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: NRas
  symbol: NRAS
  source: hgnc_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
chemicals:
- word: Manumycin H
  source: MESH
  identifier: C054474
- word: UO126
  source: MESH
  identifier: C113580
diseases: []
---
